Document:

Prepared by R.R. Donnelley Financial -- EX-4.4

 Exhibit 4.4 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT. 
 Date of Issuance 

September 3, 2014 
 ASANTE
SOLUTIONS, INC. 
 WARRANT TO PURCHASE SHARES OF SERIES A-3 PREFERED STOCK 

For the consideration stipulated in that certain Series A-3 Preferred Stock and Warrant Purchase Agreement (as the same may be amended from
time to time, the “Purchase Agreement”) dated as of September 3, 2014, among the Company, the undersigned and certain other investors, the receipt and sufficiency of which are hereby acknowledged, this Warrant is issued to
[                ] or its assigns (the “Holder”) by Asante Solutions, Inc., a Delaware corporation (the “Company”).
Capitalized terms not defined herein shall have the meaning set forth in the Purchase Agreement. 
 1. Purchase of Shares. 

(a) Number of Shares of Series A-3 Preferred Stock. Subject to the terms and conditions set forth herein and set forth in the Purchase
Agreement, the Holder is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase from the Company up to
[                ] shares of Series A-3 Preferred Stock (as adjusted pursuant to Section 6 hereof). 

(b) Exercise Price. The purchase price for the Series A-3 Preferred Stock issuable pursuant to this Section 1 shall be $0.01 per
share. The shares of Series A-3 Preferred Stock and the per share purchase price of such shares of Series A-3 Preferred Stock shall be subject to adjustment pursuant to Section 6 hereof. Such purchase price, as adjusted from time to time, is
herein referred to as the “Exercise Price.” 
 2. Exercise Period. This Warrant shall be exercisable, in whole or in
part, during the term commencing on the Date of Issuance set forth above and ending on the earlier of (a) 5:00 p.m. Pacific Standard Time on September 3, 2019, (b) the consummation of a Deemed Liquidation (as defined in the
Company’s Amended and Restated Certificate of Incorporation (the “Restated Certificate”)) or (c) the consummation of the Company’s Initial Public Offering (as defined in the Rights Agreement) (the “Exercise
Period”). Any exercise of this Warrant may be made contingent upon the actual consummation of such Deemed Liquidation or Initial Public 

  
 1 

 
Offering, as applicable. In the event of a Deemed Liquidation or Initial Public Offering, the Company shall provide the notice to the Holder pursuant to Section 12 hereof at least
ten (10) business days prior to the consummation of such Deemed Liquidation or Initial Public Offering. 
 3. Method of
Exercise. 
 (a) While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may
exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 
 (i) the surrender of the
Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and 

(ii) the payment to the Company of an amount equal to the aggregate Exercise Price for the number of shares of Series A-3 Preferred Stock
being purchased. 
 (b) Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on
the day on which this Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name or names any certificate for the shares of Series A-3 Preferred Stock shall be issuable upon such
exercise as provided in Section 3(c) below, shall be deemed to have become the holder or holders of record of the shares of Series A-3 Preferred Stock represented by such certificate. 

(c) As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within twenty (20) days thereafter,
the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct: 

(i) a certificate or certificates for the number of shares of Series A-3 Preferred Stock to which such Holder shall be entitled, and 

(ii) in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate on the
face or faces thereof for the number of shares of Series A-3 Preferred Stock equal to the number of such shares of Series A-3 Preferred Stock called for on the face of this Warrant minus the number of shares of Series A-3 Preferred Stock purchased
by the Holder upon all exercises made in accordance with Section 3(a) above or Section 4 below. 
 4. Net Exercise; Automatic
Exercise. 
 (a) Net Exercise. In lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the
value of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with notice of such election (a “Net Exercise”). A Holder who Net Exercises shall have the
rights described in Sections 3(b) and 3(c) hereof, and the Company shall issue to such Holder a number of shares of Series A-3 Preferred Stock computed using the following formula: 

  
 2 

											
		 	X=	 	Y(A – B)	 		 		 	
		 	 	A	 		 		 	

 Where: 
  

	 	X =	The number of shares of Series A-3 Preferred Stock to be issued to the Holder. 	 

  

	 	Y =	The number of shares of Series A-3 Preferred Stock purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being cancelled (at the date of such calculation).
	 

  

	 	A =	The fair market value of one (1) share of Series A-3 Preferred Stock (at the date of such calculation). 	 

  

	 	B =	The Exercise Price (as adjusted to the date of such calculations). 	 

 For purposes of this Section 4, in the event that this Warrant is exercised pursuant to this
Section 4 in connection with the Company’s Initial Public Offering, the fair market value per share of Series A-3 Preferred Stock shall be the product of (a) the mid-point of the initial range of offering prices published in a
registration statement filed in connection with the Company’s Initial Public Offering and (b) the number of shares of Common Stock into which the shares of Series A-3 Preferred Stock are convertible into at the time of such exercise. If
the Series A-3 Preferred Stock is not traded on the over-the-counter market, an exchange or an electronic securities market, the fair market value shall be the price per share of Series A-3 Preferred Stock that the Company could obtain from a
willing buyer for shares of Series A-3 Preferred Stock sold by the Company from authorized but unissued shares of Series A-3 Preferred Stock, as such prices shall be determined in good faith by the Company’s Board of Directors. 

(b) Automatic Exercise. If the Holder of this Warrant has not elected to exercise this Warrant prior to expiration of this Warrant
pursuant to Section 2, then this Warrant shall automatically (without any act on the part of the Holder) be exercised pursuant to Section 4(a), effective immediately prior to the expiration of the Warrant, to the extent such net issue
exercise would result in the issuance of shares of capital stock of the Company, unless Holder shall earlier provide written notice to the Company that the Holder desires that this Warrant expire unexercised. If this Warrant is automatically
exercised, the Company shall notify the Holder of the automatic exercise as soon as reasonably practicable, and the Holder shall surrender the Warrant to the Company in accordance with the terms hereof. 

  
 3 

 5. Covenants of the Company. 

(a) Notices of Record Date. In the event of any taking by the Company of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend which is the same as cash dividends paid in previous quarters or a stock dividend) or other distribution, the Company shall mail to the
Holder, at least ten (10) business days prior to such record date, a notice specifying the date on which any such record is to be taken for the purpose of such dividend or distribution. 

(b) Covenants as to Exercise Shares. The Company covenants and agrees that all shares of Series A-3 Preferred Stock that may be issued
upon the exercise of the rights represented by this Warrant will, upon issuance in accordance with the terms hereof, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the
issuance thereof. If at any time during the Exercise Period the number of authorized but unissued shares of capital stock shall not be sufficient to permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion
of its counsel, be necessary to increase its authorized but unissued shares of capital stock to such number of shares as shall be sufficient for such purposes. 

6. Adjustment of Exercise Price and Number of Shares of Series A-3 Preferred Stock. The number of shares of Series A-3 Preferred Stock
purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a)
Subdivisions, Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of this Warrant subdivide its Series A-3 Preferred Stock, by split-up or otherwise, or combine its Series A-3
Preferred Stock, or issue additional shares of its Series A-3 Preferred Stock as a dividend with respect to any shares of its Series A-3 Preferred Stock, the number of shares of Series A-3 Preferred Stock issuable on the exercise of this Warrant
shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price payable per share, but the
aggregate Exercise Price payable for the total number of shares of Series A-3 Preferred Stock purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 6(a) shall become effective at the close of
business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend. 

(b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the
capital stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 6(a) above), then, as a condition of such reclassification, reorganization or change, lawful provision shall be made,
and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to
that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification, reorganization or change by a holder of the same number and type of
securities as were purchasable as Series A-3 Preferred Stock by the Holder 

  
 4 

 
immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that the
provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made to the Exercise Price per share of Series A-3 Preferred
Stock payable hereunder; provided the aggregate Exercise Price shall remain the same. 
 (c) Notice of Adjustment. When any
adjustment is required to be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of shares of Series A-3 Preferred
Stock or other securities or property thereafter purchasable upon exercise of this Warrant. 
 (d) Conversion of Series A-3 Preferred
Stock. In the event that all outstanding shares of Series A-3 Preferred Stock are converted to Common Stock, or any other security, in accordance with the terms of the Company’s Restated Certificate, before this Warrant is exercised or
cancelled, this Warrant shall become exercisable for Common Stock or such other security. 
 7. No Fractional Shares or Scrip. No
fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

8. No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with
respect to the shares of Series A-3 Preferred Stock underlying this Warrant, including (without limitation) the right to vote such shares of Series A-3 Preferred Stock, receive dividends or other distributions thereon, exercise preemptive rights or
be notified of stockholder meetings, and, except as otherwise provided in this Warrant or the Purchase Agreement, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company by
reason of this Warrant, but shall have such rights as may be afforded such Holder in respect of the shares of Series A-3 Preferred Stock underlying this Warrant as may be set forth in other written agreements between the Company and the Holder. 

9. Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware, regardless of the laws that
might otherwise govern under applicable principle of conflicts of law. 
 10. Successors and Assigns. This Warrant applies to, inures
to the benefit of, and binds the successors and assigns of the parties hereto. Any transfer of this Warrant may be effected only (a) pursuant to Section 7.7 of the Purchase Agreement and (b) by surrender of this Warrant to the Company
and reissuance of a new warrant to the transferee. The Holder and any subsequent holder of this Warrant receives this Warrant subject to the foregoing terms and conditions, and agrees to comply with the foregoing terms and conditions for the benefit
of the Company. 

  
 5 

 11. Titles and Subtitles. The titles and subtitles used in this Warrant are used for
convenience only and are not to be considered in construing or interpreting this Warrant. 
 12. Notices. All notices and other
communications given or made pursuant hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) upon posting to the e-mail or facsimile address of the recipient; provided
a hard copy is sent by regular mail, (c) five (5) days after having been sent by first class mail, postage prepaid, or (d) one (1) business day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. All communications shall be sent to the respective parties at the following addresses (or at such other addresses as shall be specified by notice given in accordance with this Section 12): 

If to the Company: 
 Asante
Solutions, Inc. 
 352 East Java Drive 

Sunnyvale, CA 94089 
 Attn: Chief
Executive Officer 
 E-mail: [redacted] 

with a copy (which shall not constitute notice) to: 

Goodwin Procter LLP 
 135
Commonwealth Drive 
 Menlo Park, California 94025 

Attn: Richard A. Kline 
 Fax:
[redacted] 
 E-mail: [redacted] 

If to Holder: 
 At the addresses
shown on the signature pages to the Purchase Agreement. 
 13. Amendments and Waivers; Resolutions of Dispute: Notice. Any term of
this Warrant may be amended, and the observance thereof waived, either prospectively or retrospectively, and either in a particular instance or generally, only upon the written consent of (a) the Company and (b) holders of Warrants
representing at least 75% of the Series A-3 Preferred Stock then issuable upon exercise of all such Warrants then outstanding; provided that such amendment and/or waiver, is made on a pro rata, pari passu basis across all Warrants. 

14. Severability. If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded
from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

[The remainder of this page is intentionally left blank.] 

  
 6 

 IN WITNESS WHEREOF, the parties Company has executed this Warrant as of the date above written.

  

			
	COMPANY:
	
	ASANTE SOLUTIONS, INC.
		
	By:	 	 
	Name: David Thrower
	Title: Chief Executive Officer

  

	
	Acknowledged and Agreed:
	
	[HOLDER SIGNATURE BLOCK]
	
	Address of Holder:
	
	   

	
	   

	
	   

	
	   

  
 1 

 NOTICE OF EXERCISE 

ASANTE SOLUTIONS, INC. 
 Attention: Corporate Secretary

 The undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows: 

 

	        	                     shares of Series A-3 Preferred Stock pursuant to the terms of the attached Warrant, and
tenders herewith payment in cash of the Exercise Price of such shares of Series A-3 Preferred Stock in full, together with all applicable transfer taxes, if any. 

 

	        	Net Exercise the attached Warrant with respect to                      shares of Series A-3 Preferred Stock (on
a post-net exercise basis). 

 The undersigned hereby represents and warrants that Representations and warranties in
Section 4 of the Purchase Agreement are true and correct as of the date of exercise, with respect to the Holder and the shares of Series A-3 Preferred Stock to be issued upon exercise. 

 

									
		 		 		 	HOLDER:
					
	Date:	 	 	 		 	By:	 	 
					
		 		 		 	Address:	 	 
					
		 		 		 		 	 
	Name in which shares should be registered:	 		 		 	
				
	   
	 	  
	 	  
	 	  

  
 2 

 ASSIGNMENT FORM 

(TO ASSIGN THE FOREGOING WARRANT,
EXECUTE THIS FORM AND SUPPLY REQUIRED INFORMATION. DO NOT USE THIS
FORM TO PURCHASE SHARES.) 
 FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to 
  

			
	Name:	 	 
	(Please Print)

  

			
	Address:	 	 
	(Please Print)

  

			
	Dated:	 	 

  

			
	 Holder’s
 Signature:
	 	 

  

			
	 Holder’s
 Signature:
	 	 

 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant. Officers
of corporations and those acting in a fiduciary or other representative capacity should provide proper evidence of authority to assign the foregoing Warrant. 

  
 3Prepared by R.R. Donnelley Financial -- EX-4.5

 Exhibit 4.5 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT
REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT. 
 WARRANT TO PURCHASE STOCK 

 

			
	Corporation:	  	Asante Solutions, Inc.
	Number of Shares:	  	300,000
	Class of Stock:	  	Series A-3 Preferred
	Initial Exercise Price:	  	$1.00 per share
	Issue Date:	  	November 14, 2014
	Expiration Date:	  	November 14, 2024

 THIS WARRANT CERTIFIES THAT,
for good and valuable consideration, the receipt of which is hereby acknowledged, ALEXANDRIA EQUITIES, LLC or its assignee (“Holder”) is entitled to purchase the number of fully paid and
nonassessable shares of the class of securities (the “Shares”) of the corporation (the “Company”) at the initial exercise price per Share (the “Warrant Price”) all as set forth
above and as adjusted pursuant to Article 2 of this warrant, subject to the provisions and upon the terms and conditions set forth in this warrant. 

ARTICLE 1 
 EXERCISE

 1.1 Method of Exercise. Holder may exercise this warrant by delivering this warrant and a duly executed Notice of Exercise in
substantially the form attached as Appendix 1 to the principal office of the Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate Warrant Price
for the Shares being purchased. 
 1.2 Conversion Right. In lieu of exercising this warrant as specified in Section 1.1, Holder
may from time to time convert this warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this warrant minus the
aggregate Warrant Price of such Shares by (b) the fair market value of one Share. The fair market value of the Shares shall be determined pursuant to Section 1.3. 

1.3 Fair Market Value. If the Shares are traded regularly in a public market, the fair market value of the Shares shall be the closing
price of the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the Shares are not

 
regularly traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. 

1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this warrant, the Company shall deliver to
Holder certificates for the Shares acquired and, if this warrant has not been fully exercised or converted and has not expired, a new warrant representing the Shares not so acquired. 

1.5 Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, on surrender and cancellation of this warrant,
the Company at its expense shall execute and deliver, in lieu of this warrant, a new warrant of like tenor. 
 1.6 Repurchase on Sale,
Merger, or Consolidation of the Company. 
 1.6.1 “Acquisition.” For the purpose of this warrant,
“Acquisition” means (a) any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or (b) any reorganization, consolidation, merger or sale of the voting
securities of the Company or any other transaction where the holders of the Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction. 

1.6.2 Exercise Upon Acquisition. Upon the closing of any Acquisition in which the consideration to be received by the Company’s
stockholders consists of cash, marketable securities, or a combination of both cash and marketable securities, this warrant shall be deemed to have been automatically converted pursuant to Section 1.2, and thereafter Holder shall participate in
the Acquisition on the same terms as other holders of the same class of securities of the Company. 
 1.6.3 Assumption of Warrant.
Upon the closing of any Acquisition not referred to in Section 1.6.2, the successor entity shall assume the obligations of this warrant, and this warrant shall thereafter be exercisable for the same securities and/or other property as would
have been paid for the Shares issuable upon exercise of the unexercised portion of this warrant as if such Shares were outstanding on and as of the closing of such Acquisition, subject to further adjustment from time to time in accordance with the
provisions of this warrant. 
 ARTICLE 2 

ADJUSTMENTS TO THE SHARES 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on its common stock payable in common stock, or other
securities, or subdivides the outstanding common stock into a greater amount of common stock, then upon exercise of this warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which
Holder would have been entitled had Holder owned the Shares of record as of the date the dividend or subdivision occurred. 

 2.2 Reclassification, Exchange or Substitution. Upon any reclassification, exchange,
substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this warrant, Holder shall be entitled to receive, upon exercise or conversion of this warrant, the number and
kind of securities and property that Holder would have received for the Shares if this warrant had been exercised immediately before such reclassification, exchange, substitution, or other event. Such an event shall include any automatic conversion
of the outstanding or issuable securities of the Company of the same class or series as the Shares to common stock pursuant to the terms of the Company’s Certificate of Incorporation (the “Charter”) upon the closing of a
registered public offering of the Company’s common stock. The Company or its successor shall promptly issue to Holder a new warrant for such new securities or other property. The new warrant shall provide for adjustments which shall be as
nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new warrant. The
provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, substitutions, or other events. 

2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or consolidated, by reclassification or otherwise, into a
lesser number of shares, the Warrant Price shall be proportionately increased. If the outstanding Shares are combined or consolidated, by reclassification or otherwise, into a greater number of shares, the Warrant Price shall be proportionately
decreased. 
 2.4 Adjustments for Diluting Issuances. In the event of the issuance (a “Diluting Issuance”) by
the Company after the Issue Date (except (i) securities excluded from the definition of “Additional Stock” pursuant to the Charter or (ii) Diluting Issuances that are otherwise waived with respect to the holders of the
Company’s Series A-3 Preferred Stock pursuant to the terms of the Charter) of securities at a price per share less than the Warrant Price, then the number of shares of common stock issuable upon conversion of the Shares shall be adjusted in
accordance with those provisions of the Charter that apply to Diluting Issuances. 
 2.5 Certificate as to Adjustments. Upon each
adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon which such adjustment is based.
The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price. 

2.6 Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of the Warrant and the Number of Shares to be
issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall eliminate such fractional share interest by paying Holder the amount computed by
multiplying the fractional interest by the fair market value of a full Share. 

 ARTICLE 3 

REPRESENTATIONS AND COVENANTS OF THE COMPANY 

3.1 Representations and Warranties. The Company hereby represents and warrants to Holder as follows: 

(a) The initial Warrant Price referenced on the first page of this warrant is not greater than the fair market value of the Shares as
of the date of this warrant. 
 (b) All Shares which may be issued upon the exercise of the purchase right represented by this
warrant, and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided
for herein or under applicable federal and state securities laws. 
 (c) The Company’s capitalization table attached to this
warrant is true and complete as of the Issue Date. 
 3.2 Notice of Certain Events. The Company shall provide Holder with not less
than 10 days prior written notice of, including a description of the material facts surrounding, any of the following events: (a) declaration of any dividend or distribution upon its common stock, whether in cash, property, stock, or other
securities and whether or not a regular cash dividend; (b) offering for subscription pro rata to the holders of any class or series of its stock any additional shares of stock of any class or series or other rights; (c) effecting any
reclassification or recapitalization of common stock; or (d) the merger or consolidation with or into any other corporation, or sale, lease, license, or conveyance of all or substantially all of its assets, or liquidation, dissolution or
winding up. 
 3.3 Information Rights. So long as Holder holds this warrant and/or any of the Shares, the Company shall deliver to
Holder (a) promptly after mailing, copies of all communiques to the shareholders of the Company, (b) within one hundred eighty (180) days after the end of each fiscal year of the Company, the annual audited financial statements of the
Company certified by independent public accountants of recognized standing and (c) within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial
statements. 
 3.4 Registration Under Securities Act of 1933, as amended. The Company agrees that the Shares or, if the Shares are
convertible into common stock of the Company, such common stock, shall be “Registrable Securities”, and Holder shall be a “Holder” under the Investor Rights Agreement among the Company and other persons dated as of
September 3, 2014, solely for the purposes of obtaining the piggyback registration rights contained in Sections 2 and 5 thereof. 

 ARTICLE 4 

MISCELLANEOUS 
 4.1
Term; Exercise Upon Expiration. This warrant is exercisable in whole or in part, at any time and from time to time on or before the Expiration Date set forth above; provided, however, that if the Company completes its initial public offering
within the three-year period immediately prior to the Expiration Date, the Expiration Date shall automatically be extended or contracted to be the third anniversary of the effective date of the Company’s initial public offering. If this warrant
has not been exercised prior to the Expiration Date, this warrant shall be deemed to have been automatically exercised on the Expiration Date by “cashless” conversion pursuant to Section 1.2. 

4.2 Legends. This warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any)
shall be imprinted with a legend in substantially the following form: 
 “THIS WARRANT AND THE SECURITIES ISSUABLE UPON
THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.” 

4.3 Compliance with Securities Laws on Transfer. This warrant and the Shares issuable upon exercise of this warrant (and the securities
issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee. The Company
shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder or if there is no material question as to the availability of current information as referenced in Rule 144(c), Holder represents that it has
complied with Rule 144 (d) and (e) in reasonable detail, the selling broker represents that it has complied with Rule 144(f), and the Company is provided with a copy of Holder’s notice of proposed sale. 

4.4 Transfer Procedure. Subject to the provisions of Section 4.3, Holder may transfer all or part of this warrant or the Shares
issuable upon exercise of this warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice of the portion of the warrant being transferred setting forth the name, address and
taxpayer identification number of the transferee and surrendering this warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable). No surrender or reissuance shall be required if the transfer is to an affiliate of Holder.

 4.5 Notices. All notices and other communications from the Company to Holder, or vice versa, shall be deemed delivered and
effective when given personally or mailed by first-

 
class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to
time. All notices to Holder shall be addressed as follows: 
 Alexandria Equities, LLC 

Attn: Corporate Secretary 
 385 E.
Colorado Blvd., Suite 299 
 Pasadena, CA 91101 

FAX: [redacted] 
 With a copy to:

 Email: [redacted] 
 4.6
Amendments. This warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 

4.7 Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of this warrant, the
party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees. 

4.8 Governing Law. This warrant shall be governed by and construed in accordance with the laws of the State of California, without
giving effect to its principles regarding conflicts of law. 

 IN WITNESS WHEREOF, the undersigned has executed this Warrant to Purchase Stock as of the date
set forth above. 
  

			
	ASANTE SOLUTIONS, INC.
		
	By:	 	/s/ David Thrower
		
	Name:	 	David Thrower
		
	Title:	 	CEO

 [Signature Page to Warrant to Purchase Stock] 

 APPENDIX 1 

NOTICE OF EXERCISE 

1. The undersigned hereby elects to purchase
                 shares of the              stock of ASANTE
SOLUTIONS, INC. pursuant to the terms of the attached warrant, and tenders herewith payment of the purchase price of such shares in full. 

1. The undersigned hereby elects to convert the attached warrant into shares in the manner specified in the warrant. This conversion is
exercised with respect to                  of the shares covered by the warrant. 

[Strike paragraph that does not apply.] 

2. Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is
specified below: 
 Alexandria Equities, LLC 

Attn: Corporate Secretary 
 385 E.
Colorado Blvd., Suite 299 
 Pasadena, CA 91101 

FAX: [redacted] 
 With a copy to:

 Email: [redacted] 

3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not
with a view toward the resale or distribution thereof except in compliance with applicable securities laws. 
  

	
	ALEXANDRIA EQUITIES, LLC or Registered Assignee
	
	   

	(Signature)
	
	   

	(Date)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]